Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The course, intended for healthcare professionals, provides an overview of biosimilar products and FDA’s biosimilar product development programs.

FDA Releases Online Course on Biosimilars

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.

Vaccines Prove Effective and Cost-Effective

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

There are no clinically meaningful differences between Celltrion’s CT-P13 and Remicade, according to an FDA briefing released ahead of the formal panel meeting.

Celltrion’s Biosimilar to Remicade Likely to be Approved for All Indications

Although switching has occurred in European markets for some biosimilars, most biosimilar manufacturers will focus on securing new users, according to Merck.

Merck: Biosimilar Makers Likely to Target New Patients

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Expanded systems integration, serialization, and supply chain connectivity will enhance productivity and support counterfeit prevention.

Parenteral Packagers Focus on Security and Supply-Chain Transparency

Common defects in tablet film coating can be minimized by effective design of the tablet core and the coating process.

Preventing Film Coating Problems by Design

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.

Going Small to Achieve Commercial-Scale Success

The Biosimilars Forum launched Partnership for Biosimilars Education and Access, an education initiative raising awareness of biosimilars in the US.

Biosimilars Forum Launches Education Initiative

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

The reporter bioassay, used to evaluate ADCC activity of therapeutic antibodies, complements the classical ADCC assay.

Assessing Antibody-Dependent Cell-Mediated Cytotoxicity

Hermes Pharma has commercially implemented hot-melt coating (HMC) technology at its production facility.